Skip to main content
. 2015 Jan 8;26(1):32–39. doi: 10.3802/jgo.2015.26.1.32

Table 4.

Comparison of patients group, adjuvant treatments, and recurrences according to the Gynecology Oncology Group and simplified criteria

graphic file with name jgo-26-32-i004.jpg

GOG, Gynecologic Oncology Group; HIR, high-intermediate risk; LIR, low-intermediate risk; NS, not significant.

*Based on 1988 International Federation of Gynecology and Obstetrics (FIGO) staging system. †Based on 2009 FIGO staging system. ‡For the patients who adhered to the GOG and simplified criteria, there was no significant difference in the rate of disease recurrence.